Newsletters
-
PD for Thu 20 Apr 2023
Thursday | Apr 20 2023APC opens accreditation consultation, API targeting SILK Laser, AI tool for AS diagnosis, and more.
-
PD for Wed 19 Apr 2023
Wednesday | Apr 19 2023CMA head to retire, oral insulin in the pipeline, Guild gets flack over full scope in survey, Ghana approves malaria vaccine, and more.
-
PD for Tue 18 Apr 2023
Tuesday | Apr 18 2023Sigma to pursue growth, Merck to buy Prometheus for A$16b, UK community pharmacy chain merger, and more.
-
PD for Mon 17 Apr 2023
Monday | Apr 17 2023TGA investigates vaping posts on TikTok, SSSI made for Penicillin V, UK's stop-to-swap scheme, and more.
-
PD for Fri 14 Apr 2023
Friday | Apr 14 2023Latest salvo from RACGP on 7CPA funding, Ozempic limited till Jun, NAC puts out new asthma chart, and more.
-
PD for Thu 13 Apr 2023
Thursday | Apr 13 2023Brendan Murphy will step down, Topamax linked to birth defects, PCA rollout starts, and more.
-
PD for Wed 12 Apr 2023
Wednesday | Apr 12 2023PSA to counsel on women's health, TWC brings on WorkJam, Z software and Medi-Map merger, and more.
-
PD for Tue 11 Apr 2023
Tuesday | Apr 11 2023Essure class action starts, dual labelling of ingredients ends soon, AMA's latest anti-pharmacy prescribing campaign, and more.
-
PD for Thu 06 Apr 2023
Thursday | Apr 6 2023Guild campaign to repush to lower co-payments, new PSA CEO, CW pharmacist wins Pride award, and more.
-
PD for Wed 05 Apr 2023
Wednesday | Apr 5 2023Westpac report shows pharmacy thriving, L'Oreal buys Aesop for $3.7b, Healthengine seeks new CEO, and more.